Genoss Co., Ltd.
Genoss Co., Ltd.
Explore linked clinical trials.14 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD | Multi Vessel Coronary Artery Disease; Percutaneous Coronary Intervention | Recruiting | Not applicable | 2026-10-09 | NCT07539324 | |
| One-Year Results of GENOSS PCB Real-World Study in Femoropopliteal Artery Disease | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, aortopulmonary window, cardiovascular disorder, congenital heart disease, heart disorder, heart septal defect, persistent truncus arteriosus | Enrolling by invitation | Not stated | 2026-09-11 | NCT07431437 | |
| Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, aortopulmonary window, cardiovascular disorder, congenital heart disease, heart disorder, heart septal defect, persistent truncus arteriosus | Recruiting | Not stated | 2026-09-11 | NCT07425171 | |
| Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome | Angina Pectoris, Chest Pain, Infarction, Necrosis, Neurologic Manifestations, Non-ST Elevated Myocardial Infarction, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, Signs and Symptoms, acute coronary syndrome, cardiovascular disorder, heart disorder, intermediate coronary syndrome, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Not yet recruiting | Phase 4 | 2026-07-06 | NCT07684742 | |
| Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, aortopulmonary window, cardiovascular disorder, congenital heart disease, heart disorder, heart septal defect, persistent truncus arteriosus | Enrolling by invitation | Not stated | 2026-02-18 | NCT07399080 | |
| Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS) | acute coronary syndrome, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not stated | 2026-02-11 | NCT06075368 | |
| Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease | Multivessel Coronary Artery Disease; Percutaneous Coronary Intervention | Enrolling by invitation | Not stated | 2025-10-06 | NCT06168305 | |
| Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES) | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Enrolling by invitation | Not stated | 2025-10-06 | NCT06086496 | |
| Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease | Coronary Arterial Disease (CAD) | Active, not recruiting | Not stated | 2025-09-16 | NCT06841510 | |
| The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus 'SeQuent® Please NEO' in Patients With Coronary ISR | Coronary Arterial Disease (CAD) | Enrolling by invitation | Not applicable | 2025-09-08 | NCT07159087 | |
| Safety and Efficacy of GENOSS® DCB With a Shellac Plus Vitamin E Excipient in Patients With De Novo Lesion | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Enrolling by invitation | Not stated | 2025-09-05 | NCT07158307 | |
| Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2025-02-21 | NCT06075433 | |
| Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease | Dual Antiplatelet Therapy; Percutaneous Coronary Intervention | Recruiting | Not stated | 2025-02-21 | NCT06075420 | |
| Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2023-11-01 | NCT06066450 |